Mireia Margelí Vila
- Oncology top 5%
- Cancer Research top 5%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 5%
- Surgery
- Co-authors
- Eudald FelipAgustí BarnadasMiquel TarónRafael RosellAdrià Bernat‐PegueraJosé Á. García-SáenzMontserrat Muñoz-MateuJosé Luís Zamora Manzano
- Topics
- Breast Cancer Treatment Studies (35 papers)Advanced Breast Cancer Therapies (33 papers)HER2/EGFR in Cancer Research (28 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Mireia Margelí Vila
88 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 83
- Oncology 784
- Cancer Research 485
- Molecular Biology 440
- Pulmonary and Respiratory Medicine 416
- Surgery 174
Countries citing papers authored by Mireia Margelí Vila
This map shows the geographic impact of Mireia Margelí Vila's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mireia Margelí Vila with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mireia Margelí Vila more than expected).
Fields of papers citing papers by Mireia Margelí Vila
This network shows the impact of papers produced by Mireia Margelí Vila. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mireia Margelí Vila. The network helps show where Mireia Margelí Vila may publish in the future.
Co-authorship network of co-authors of Mireia Margelí Vila
This figure shows the co-authorship network connecting the top 25 collaborators of Mireia Margelí Vila. A scholar is included among the top collaborators of Mireia Margelí Vila based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mireia Margelí Vila. Mireia Margelí Vila is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 6 | |
| 6 | 9 | |
| 7 | 3 | |
| 8 | 32 | |
| 9 | 2 | |
| 10 | 3 | |
| 11 | 29 | |
| 12 | 6 | |
| 13 | 6 | |
| 14 | 47 | |
| 15 | 10 | |
| 16 | 1 | |
| 17 | 2 | |
| 18 | 26 | |
| 19 | 11 | |
| 20 | 11 |
About Mireia Margelí Vila
Mireia Margelí Vila is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 94 papers that have together received 1.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (35 papers), Advanced Breast Cancer Therapies (33 papers) and HER2/EGFR in Cancer Research (28 papers). The work is most often cited by research in Cancer Research (485 citations), Oncology (784 citations) and Family Practice (50 citations). Mireia Margelí Vila has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Eudald Felip, Agustí Barnadas, Miquel Tarón, Rafael Rosell, Adrià Bernat‐Peguera, José Á. García-Sáenz, Montserrat Muñoz-Mateu, José Luís Zamora Manzano, Ignasi Tusquets and José Miguel Sánchez. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.